Invesco
BEAM icon

Invesco’s Beam Therapeutics BEAM Stock Holding History

Invesco’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.66M Sell
194,171
-25,790
-12% -$779K ﹤0.01% 2104
2026
Q1 		$5.24M Buy
219,961
+6,776
+3% +$188K ﹤0.01% 2167
2025
Q4 		$5.91M Buy
213,185
+36,321
+21% +$927K ﹤0.01% 2164
2025
Q3 		$4.29M Buy
176,864
+47,990
+37% +$955K ﹤0.01% 2296
2025
Q2 		$2.19M Buy
128,874
+40,583
+46% +$707K ﹤0.01% 2541
2025
Q1 		$1.72M Buy
88,291
+22,026
+33% +$577K ﹤0.01% 2594
2024
Q4 		$1.64M Buy
66,265
+2,701
+4% +$68.9K ﹤0.01% 2688
2024
Q3 		$1.56M Sell
63,564
-1,128
-2% -$29.1K ﹤0.01% 2723
2024
Q2 		$1.52M Sell
64,692
-677
-1% -$16.6K ﹤0.01% 2730
2024
Q1 		$2.16M Buy
65,369
+17,208
+36% +$536K ﹤0.01% 2634
2023
Q4 		$1.31M Sell
48,161
-1,870
-4% -$46.5K ﹤0.01% 2775
2023
Q3 		$1.2M Sell
50,031
-344
-0.7% -$9.22K ﹤0.01% 2784
2023
Q2 		$1.61M Sell
50,375
-282
-0.6% -$9.15K ﹤0.01% 2707
2023
Q1 		$1.55M Buy
50,657
+17,686
+54% +$698K ﹤0.01% 2737
2022
Q4 		$1.29M Buy
32,971
+4,219
+15% +$189K ﹤0.01% 2820
2022
Q3 		$1.37M Buy
28,752
+3,441
+14% +$196K ﹤0.01% 2799
2022
Q2 		$980K Buy
25,311
+3,004
+13% +$119K ﹤0.01% 3000
2022
Q1 		$1.28M Buy
22,307
+277
+1% +$18.2K ﹤0.01% 2965
2021
Q4 		$1.76M Sell
22,030
-1,305
-6% -$112K ﹤0.01% 2845
2021
Q3 		$2.03M Buy
23,335
+4,253
+22% +$427K ﹤0.01% 2800
2021
Q2 		$2.46M Buy
19,082
+8,864
+87% +$706K ﹤0.01% 2770
2021
Q1 		$818K Sell
10,218
-172,402
-94% -$16.4M ﹤0.01% 3130
2020
Q4 		$14.9M Buy
+182,620
New +$8.98M ﹤0.01% 1588

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Invesco's BEAM Position: Q2 2026 in Review

Invesco reduced its Beam Therapeutics (BEAM) stake by 12% in Q2 2026, selling an estimated $779K and leaving 194,171 shares worth $6.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

Invesco first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. The position peaked at $14.9M in Q4 2020. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Invesco held 194,171 shares of Beam Therapeutics worth $6.66M as of Q2 2026.
  • Invesco sold 25,790 Beam Therapeutics shares in Q2 2026, an estimated $779K.
  • Beam Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2104 holding.
  • Invesco first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Invesco's Beam Therapeutics position peaked at $14.9M in Q4 2020.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.